Literature DB >> 15448342

Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent.

Helena Sterlinko Grm1, Lawrence Banks1.   

Abstract

An important characteristic of the E6 proteins derived from cancer-associated human papillomaviruses (HPVs) is their ability to target cellular proteins for ubiquitin-mediated degradation. Degradation of the p53 tumour suppressor protein by E6 is known to involve the cellular ubiquitin ligase, E6-AP; however, it is presently not known how E6 targets the Drosophila discs large (Dlg) tumour suppressor and the membrane-associated guanylate kinase inverted (MAGI) family of proteins for degradation. By using an in vitro E6-AP immunodepletion assay, these targets were tested for degradation in a E6-AP-dependent manner. The data showed clearly that E6 can direct the degradation of Dlg and the MAGI family of proteins in the absence of E6-AP in this in vitro system. These results provide compelling evidence for the role of E6-associated ubiquitin ligases other than E6-AP in the degradation of certain E6 targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448342     DOI: 10.1099/vir.0.80035-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.

Authors:  Nicole Brimer; Charles Lyons; Scott B Vande Pol
Journal:  Virology       Date:  2006-10-04       Impact factor: 3.616

3.  Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.

Authors:  Sudhakar Jha; Scott Vande Pol; Nilam Sanjib Banerjee; Arun Brendan Dutta; Louise T Chow; Anindya Dutta
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

4.  Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.

Authors:  James D Baleja; Jonathan J Cherry; Zhiguo Liu; Hua Gao; Marc C Nicklaus; Johannes H Voigt; Jason J Chen; Elliot J Androphy
Journal:  Antiviral Res       Date:  2006-04-21       Impact factor: 5.970

5.  HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP.

Authors:  A Shai; M L Nguyen; J Wagstaff; Y-H Jiang; P F Lambert
Journal:  Oncogene       Date:  2006-11-27       Impact factor: 9.867

6.  Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.

Authors:  Moonju Choi; Sungjin Lee; Taekyu Choi; Choongho Lee
Journal:  Virus Genes       Date:  2013-11-29       Impact factor: 2.332

7.  PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6.

Authors:  Carina H Storrs; Saul J Silverstein
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

8.  Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein.

Authors:  Mathew A Cherian; Hicham H Baydoun; Jacob Al-Saleem; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Patrick Green; Lee Ratner
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

9.  Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53.

Authors:  Brooke Cooper; Nicole Brimer; Scott B Vande Pol
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

Review 10.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.